Compare SRBK & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRBK | GNTA |
|---|---|---|
| Founded | 1887 | 2014 |
| Country | United States | Italy |
| Employees | N/A | 13 |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7M | 19.9M |
| IPO Year | 2023 | N/A |
| Metric | SRBK | GNTA |
|---|---|---|
| Price | $17.00 | $0.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.1K | ★ 51.3K |
| Earning Date | 04-29-2026 | 03-24-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 138.36 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $84.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.38 | $0.59 |
| 52 Week High | $18.04 | $10.00 |
| Indicator | SRBK | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 54.04 | 40.34 |
| Support Level | $16.27 | $0.71 |
| Resistance Level | $17.14 | $1.70 |
| Average True Range (ATR) | 0.35 | 0.10 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 70.11 | 38.36 |
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.